Mark Andrews

Person

Kent, GB

People

Patents Grantslast 30 patents

Information Patent Grant
Pyrrolo[3,2-c]pyridine tropomyosin-related kinase inhibitors
- Patent number 9,163,021
- Issue date Oct 20, 2015
- Pfizer Limited
- Mark David Andrews
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrrolo[2,3-d]pyrimidine tropomysin-related kinase inhibitors
- Patent number 8,846,698
- Issue date Sep 30, 2014
- Pfizer Limited
- Mark David Andrews
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Diazepine and diazocane compounds as MC4 agonists
- Patent number 8,592,403
- Issue date Nov 26, 2013
- Pfizer Limited
- Mark David Andrews
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Melanocortin type 4 receptor agonist piperidinoylpyrrolidines
- Patent number 8,138,188
- Issue date Mar 20, 2012
- Pfizer Inc.
- Mark David Andrews
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrimido [4,5-D] azepine derivatives as 5-HT2c agonists
- Patent number 7,928,099
- Issue date Apr 19, 2011
- Pfizer Inc.
- Mark Andrews
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds
- Patent number 7,378,436
- Issue date May 27, 2008
- Pfizer Inc.
- Paul Vincent Fish
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Phenyl heterocyclyl ethers
- Patent number 7,129,234
- Issue date Oct 31, 2006
- Pfizer Inc.
- Mavis D. Adam
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Diaryl compounds
- Patent number 6,800,652
- Issue date Oct 5, 2004
- Pfizer Inc.
- Mark David Andrews
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Phenoxyphenylheterocyclyl derivatives as SSRIs
- Patent number 6,630,504
- Issue date Oct 7, 2003
- Pfizer Inc.
- Mark David Andrews
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Phenoxybenzylamine derivatives as SSRIs
- Patent number 6,610,747
- Issue date Aug 26, 2003
- Pfizer Inc.
- Mavis Diane Adam
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Diphenyl ether compounds useful in therapy
- Patent number 6,448,293
- Issue date Sep 10, 2002
- Pfizer Inc.
- Mark David Andrews
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
Tropomyosin-Related Kinase Inhibitors
- Publication number 20150250785
- Publication date Sep 10, 2015
- Pfizer Limited
- Mark David Andrews
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Pyrrolo[3,2-C]Pyridine Tropomyosin-Related Kinase Inhibitors
- Publication number 20150246912
- Publication date Sep 3, 2015
- PFIZER LIMITED
- Mark David Andrews
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Pyrrolo[2,3-D]Pyrimidine Tropomyosin-Related Kinase Inhibitors
- Publication number 20150218172
- Publication date Aug 6, 2015
- Pfizer Limited
- Mark David Andrews
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PYRROLO[2,3-d]PYRIMIDINE TROPOMYSIN-RELATED KINASE INHIBITORS
- Publication number 20140364415
- Publication date Dec 11, 2014
- PFIZER LIMITED
- Mark David Andrews
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PYRROLO[2,3-d]PYRIMIDINE TROPOMYSIN-RELATED KINASE INHIBITORS
- Publication number 20120258950
- Publication date Oct 11, 2012
- PFIZER LIMITED
- Mark David Andrews
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Diazepine and Diazocane Compounds As MC4 Agonists
- Publication number 20110136814
- Publication date Jun 9, 2011
- Mark David Andrews
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Pyrimido [4,5-D] Azepine Derivatives As 5-HT2C Agonists
- Publication number 20100113422
- Publication date May 6, 2010
- Mark Andrews
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Melanocortin Type 4 Receptor Agonist Piperidinoylpyrrolidines
- Publication number 20090036459
- Publication date Feb 5, 2009
- Pfizer Inc.
- Mark David Andrews
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL COMPOUNDS
- Publication number 20080306123
- Publication date Dec 11, 2008
- Pfizer Inc.
- Paul Vincent Fish
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Piperidinoyl-Pyrrolidine and Piperidinoyl-Piperidine Compounds
- Publication number 20080269233
- Publication date Oct 30, 2008
- Mark David Andrews
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Diaryl compounds
- Publication number 20050026920
- Publication date Feb 3, 2005
- Pfizer Inc.
- Mark David Andrews
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Amide derivatives as selective serotonin re-uptake inhibitors
- Publication number 20050014789
- Publication date Jan 20, 2005
- Pfizer Inc.
- Mark David Andrews
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Phenyl heterocyclyl ethers
- Publication number 20040106594
- Publication date Jun 3, 2004
- Pfizer Inc.
- Mavis D. Adam
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Diaryl compounds
- Publication number 20040097509
- Publication date May 20, 2004
- Pfizer Inc.
- Mark David Andrews
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Phenyl heterocyclyl ethers
- Publication number 20030207857
- Publication date Nov 6, 2003
- Mavis D. Adam
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Phenoxybenzylamine derivatives as SSRls
- Publication number 20030060456
- Publication date Mar 27, 2003
- Mavis Diane Adam
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Phenoxyphenylheterocyclyl derivatives as SSRIs
- Publication number 20020183303
- Publication date Dec 5, 2002
- Mark David Andrews
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Diphenyl ether compounds useful in therapy
- Publication number 20020052395
- Publication date May 2, 2002
- Mark David Andrews
- C07 - ORGANIC CHEMISTRY

Mark Andrews

Person

Patents Grantslast 30 patents

Pyrrolo[3,2-c]pyridine tropomyosin-related kinase inhibitors

Pyrrolo[2,3-d]pyrimidine tropomysin-related kinase inhibitors

Diazepine and diazocane compounds as MC4 agonists

Melanocortin type 4 receptor agonist piperidinoylpyrrolidines

Pyrimido [4,5-D] azepine derivatives as 5-HT2c agonists

Compounds

Phenyl heterocyclyl ethers

Diaryl compounds

Phenoxyphenylheterocyclyl derivatives as SSRIs

Phenoxybenzylamine derivatives as SSRIs

Diphenyl ether compounds useful in therapy

Patents Applicationslast 30 patents

Tropomyosin-Related Kinase Inhibitors

Pyrrolo[3,2-C]Pyridine Tropomyosin-Related Kinase Inhibitors

Pyrrolo[2,3-D]Pyrimidine Tropomyosin-Related Kinase Inhibitors

PYRROLO[2,3-d]PYRIMIDINE TROPOMYSIN-RELATED KINASE INHIBITORS

PYRROLO[2,3-d]PYRIMIDINE TROPOMYSIN-RELATED KINASE INHIBITORS

Diazepine and Diazocane Compounds As MC4 Agonists

Pyrimido [4,5-D] Azepine Derivatives As 5-HT2C Agonists

Melanocortin Type 4 Receptor Agonist Piperidinoylpyrrolidines

NOVEL COMPOUNDS

Piperidinoyl-Pyrrolidine and Piperidinoyl-Piperidine Compounds

Diaryl compounds

Amide derivatives as selective serotonin re-uptake inhibitors

Phenyl heterocyclyl ethers

Diaryl compounds

Phenyl heterocyclyl ethers

Phenoxybenzylamine derivatives as SSRls

Phenoxyphenylheterocyclyl derivatives as SSRIs

Diphenyl ether compounds useful in therapy